Torrent Pharmaceuticals Ltd. — AGM Information 2025

Jul 28, 2025

==> picture [93 x 31] intentionally omitted <==

28[th] July, 2025

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

Mumbai – 400 051

(NSE Scrip Code: TORNTPHARM)

Dear Sir,

Re: Proceedings of 52[nd] Annual General Meeting of the Company held on 28[th] July, 2025

In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that the following business was transacted at the 52[nd] Annual General Meeting (AGM) of the Company held through Video Conferencing on 28[th] July, 2025.

1. Approval and adoption of Standalone Financial Statements as at 31[st] March, 2025, including the Audited Balance Sheet as at 31[st] March, 2025, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon.

2. Approval and adoption of Consolidated Financial Statements as at 31[st] March, 2025, including the Audited Balance Sheet as at 31[st] March, 2025, the Statement of Profit and Loss for the year ended on that date and reports of the Auditors thereon.

3. Confirmation of payment of interim dividend of ₹ 26.00 per equity share of fully paid up face value of ₹ 5.00 each and declaration of final dividend of ₹ 6.00 per equity share of fully paid up face value of ₹ 5.00 each for the financial year ended 31[st] March, 2025.

4. To appoint a Director in place of Aman Mehta (holding DIN: 08174906), Director, who retires by rotation and being eligible, offers himself for re-appointment.

5. Ratification of remuneration of cost auditors of the Company for the year 2025-26.

6. Issuance of Equity Shares including Convertible Bonds / Debentures.

7. To appoint Secretarial Auditors of the Company

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com

==> picture [93 x 31] intentionally omitted <==

1. Appointment of Aman Mehta (holding DIN: 08174906), as Managing Director of the Company

2. Payment of Remuneration to Aman Mehta as Managing Director of the Company

3. Approval for enhancement of limit for the Loan, Guarantee and Investment by the Company under Section 186 of the Companies Act, 2013

4. Enhancement of Borrowing Limits from ₹ 15,000 Crore to ₹ 26,000 Crore

5. Creation of Charge on Company’s Properties / Assets

The above business were transacted by Remote e-voting and e-voting at the meeting as required under Companies Act, 2013, Listing Regulations and Ministry of Corporate Affairs General circular no. 20 read with Circular nos. 14 & 17 of 2020 and 09 of 2024. Declaration of Results of Voting along with Scrutinizer’s Report and Results of voting as required under Regulation 44(3) of Listing Regulations will be disclosed to the Stock Exchanges separately.

The AGM commenced at 09:30 am and concluded at 10:13 am.

Kindy take note of the above.

Thanking you,

Yours Sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN Digitally signed by CHINTAN M TRIVEDI M TRIVEDI Date: 2025.07.28 16:36:51 +05'30' CHINTAN M. TRIVEDI COMPANY SECRETARY

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com